Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.42B |
| 2 |
FedEx
FDX
|
+$1.05B |
| 3 |
Intel
INTC
|
+$848M |
| 4 |
Celanese
CE
|
+$743M |
| 5 |
RTX Corp
RTX
|
+$741M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$1.73B |
| 2 |
Comcast
CMCSA
|
+$1.5B |
| 3 |
Crown Castle
CCI
|
+$1.33B |
| 4 |
UnitedHealth
UNH
|
+$1.09B |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.7% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 13.81% |
| 4 | Industrials | 12.74% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
British American Tobacco
BTI
$124B
| $701M | 0.18% |
22,326,005
-631,763
| -3% | -$20.8M |
|
127
Broadridge
BR
$19.2B
| $698M | 0.18% |
3,899,513
+187,292
| +5% | +$33.2M |
|
128
Southern Company
SO
$107B
| $695M | 0.18% |
10,736,318
+5,153,604
| +92% | +$358M |
|
|
KRTX
129
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $675M | 0.17% |
3,990,611
-1,938
| -0% | -$364K |
|
130
Capital Group Dividend Value ETF
CGDV
$39.1B
| $651M | 0.17% |
24,595,840
+24,575,840
| +122,879% | +$672M |
|
131
ATI
ATI
$31.2B
| $627M | 0.16% |
15,225,486
+22,459
| +0.1% | +$998K |
|
132
Adobe
ADBE
$102B
| $624M | 0.16% |
1,224,339
-577,497
| -32% | -$303M |
|
133
Progressive
PGR
$121B
| $605M | 0.15% |
4,343,408
+1,593,100
| +58% | +$210M |
|
134
East-West Bancorp
EWBC
$18.6B
| $602M | 0.15% |
11,422,291
-12,999
| -0.1% | -$731K |
|
135
Church & Dwight Co
CHD
$23.9B
| $593M | 0.15% |
6,470,836
+552
| +0% | +$52.9K |
|
136
Norwegian Cruise Line
NCLH
$8.82B
| $592M | 0.15% |
35,899,058
+121,645
| +0.3% | +$2.24M |
|
137
Ametek
AME
$58.9B
| $591M | 0.15% |
3,997,978
-130,956
| -3% | -$20.5M |
|
138
Home Depot
HD
$341B
| $584M | 0.15% |
1,932,538
-222,328
| -10% | -$71.5M |
|
139
Ingersoll Rand
IR
$32.5B
| $576M | 0.15% |
+9,043,508
| New | +$602M |
|
140
Starbucks
SBUX
$125B
| $575M | 0.15% |
6,302,714
-530,502
| -8% | -$52.1M |
|
141
Molson Coors Class B
TAP
$7.83B
| $573M | 0.15% |
9,010,942
+2,124,811
| +31% | +$138M |
|
142
Ares Management
ARES
$32.8B
| $573M | 0.15% |
5,569,707
-1,015,403
| -15% | -$103M |
|
|
AXON
143
Axon Enterprise
AXON
$49.1B
| $568M | 0.14% |
2,853,688
-253,788
| -8% | -$49.9M |
|
|
EA
144
DELISTED
Electronic Arts
EA
| $564M | 0.14% |
4,681,135
+433,771
| +10% | +$54.6M |
|
145
Pfizer
PFE
$153B
| $562M | 0.14% |
16,938,256
-11,706,423
| -41% | -$414M |
|
146
Archer Daniels Midland
ADM
$38.8B
| $556M | 0.14% |
7,373,295
-9,731,970
| -57% | -$788M |
|
147
Alnylam Pharmaceuticals
ALNY
$30.3B
| $549M | 0.14% |
3,097,843
+217,200
| +8% | +$41.4M |
|
148
Fidelity National Information Services
FIS
$22B
| $547M | 0.14% |
9,888,030
+45,181
| +0.5% | +$2.6M |
|
149
Hormel Foods
HRL
$13.5B
| $541M | 0.14% |
14,216,921
+744,910
| +6% | +$29.4M |
|
150
Molina Healthcare
MOH
$10.8B
| $540M | 0.14% |
1,648,073
-217,744
| -12% | -$68.5M |
|
Similar funds
Capital International Investors's Q3 2023 Portfolio in Review
As of Q3 2023, Capital International Investors held 454 positions worth $394B, down 4.9% from $414B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital International Investors's Q3 2023 filing shows 19 new, 197 increased, 163 reduced and 20 closed positions. Its largest new stake was Ingersoll Rand: 9,043,508 shares worth $576M. The largest sale was Humana, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- Capital International Investors's largest Q3 2023 buy was Ingersoll Rand: 9,043,508 shares worth $576M.
- Capital International Investors added most to CVS Health in Q3 2023, an estimated $1.42B increase.
- Capital International Investors's biggest Q3 2023 reduction was Comcast, cutting an estimated $1.5B.
- Capital International Investors fully exited Humana in Q3 2023, selling an estimated $1.73B.
- Capital International Investors's ten largest holdings make up 27% of its $394B portfolio in Q3 2023.
- Capital International Investors opened 19 new positions and closed 20 in Q3 2023.
- Capital International Investors's portfolio value fell 4.9% quarter-over-quarter to $394B.
Based on Capital International Investors's 13F filing for Q3 2023, filed 13 Nov 2023.